Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

PHASE3RecruitingINTERVENTIONAL

Enrollment

832

Participants

Timeline

Start Date

October 7, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Old World Cutaneous Leishmaniasis

Interventions

COMBINATION_PRODUCT

drug: miltefosine with thermotherapy

see previous

Trial Locations (2)

RECRUITING

Kuchlak Primary Health Care Centre (MCH), Kuchlagh

RECRUITING

Shaheed Mohtarma Benazir Bhutto General Hospital, Quetta

All Listed Sponsors

lead

Medecins Sans Frontieres, Netherlands

OTHER